These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 24931162)

  • 1. Tyrosine phosphatase SHP2 increases cell motility in triple-negative breast cancer through the activation of SRC-family kinases.
    Sausgruber N; Coissieux MM; Britschgi A; Wyckoff J; Aceto N; Leroy C; Stadler MB; Voshol H; Bonenfant D; Bentires-Alj M
    Oncogene; 2015 Apr; 34(17):2272-8. PubMed ID: 24931162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Src-homology 2 domain-containing tyrosine phosphatase 2 promotes oral cancer invasion and metastasis.
    Wang HC; Chiang WF; Huang HH; Shen YY; Chiang HC
    BMC Cancer; 2014 Jun; 14():442. PubMed ID: 24931737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of SHP2 tyrosine phosphatase promotes the tumorigenesis of breast carcinoma.
    Hu Z; Fang H; Wang X; Chen D; Chen Z; Wang S
    Oncol Rep; 2014 Jul; 32(1):205-12. PubMed ID: 24858400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop.
    Aceto N; Sausgruber N; Brinkhaus H; Gaidatzis D; Martiny-Baron G; Mazzarol G; Confalonieri S; Quarto M; Hu G; Balwierz PJ; Pachkov M; Elledge SJ; van Nimwegen E; Stadler MB; Bentires-Alj M
    Nat Med; 2012 Mar; 18(4):529-37. PubMed ID: 22388088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGFR-activated Src family kinases maintain GAB1-SHP2 complexes distal from EGFR.
    Furcht CM; Buonato JM; Lazzara MJ
    Sci Signal; 2015 May; 8(376):ra46. PubMed ID: 25969544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Missing-in-Metastasis regulates cell motility and invasion via PTPδ-mediated changes in SRC activity.
    Chaudhary F; Lucito R; Tonks NK
    Biochem J; 2015 Jan; 465(1):89-101. PubMed ID: 25287652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shp2 Plays a Critical Role in IL-6-Induced EMT in Breast Cancer Cells.
    Sun X; Zhang J; Wang Z; Ji W; Tian R; Zhang F; Niu R
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SHP2 mediates the localized activation of Fyn downstream of the α6β4 integrin to promote carcinoma invasion.
    Yang X; Dutta U; Shaw LM
    Mol Cell Biol; 2010 Nov; 30(22):5306-17. PubMed ID: 20855525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein tyrosine phosphatase SHP2 suppresses podosome rosette formation in Src-transformed fibroblasts.
    Pan YR; Cho KH; Lee HH; Chang ZF; Chen HC
    J Cell Sci; 2013 Jan; 126(Pt 2):657-66. PubMed ID: 23178938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shp2 negatively regulates growth in cardiomyocytes by controlling focal adhesion kinase/Src and mTOR pathways.
    Marin TM; Clemente CF; Santos AM; Picardi PK; Pascoal VD; Lopes-Cendes I; Saad MJ; Franchini KG
    Circ Res; 2008 Oct; 103(8):813-24. PubMed ID: 18757826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tyrosine phosphatase SHP2 regulates focal adhesion kinase to promote EGF-induced lamellipodia persistence and cell migration.
    Hartman ZR; Schaller MD; Agazie YM
    Mol Cancer Res; 2013 Jun; 11(6):651-64. PubMed ID: 23512980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A tyrosine phosphatase SHP2 gain-of-function mutation enhances malignancy of breast carcinoma.
    Hu Z; Wang X; Fang H; Liu Y; Chen D; Zhang Q; Liu X; Wei D; Qu C; Wang S
    Oncotarget; 2016 Feb; 7(5):5664-76. PubMed ID: 26673822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells.
    Fernandis AZ; Prasad A; Band H; Klösel R; Ganju RK
    Oncogene; 2004 Jan; 23(1):157-67. PubMed ID: 14712221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRL-3 engages the focal adhesion pathway in triple-negative breast cancer cells to alter actin structure and substrate adhesion properties critical for cell migration and invasion.
    Gari HH; DeGala GD; Ray R; Lucia MS; Lambert JR
    Cancer Lett; 2016 Oct; 380(2):505-512. PubMed ID: 27452906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of Gab1 and SHP2 in paxillin tyrosine dephosphorylation and Src activation in response to epidermal growth factor.
    Ren Y; Meng S; Mei L; Zhao ZJ; Jove R; Wu J
    J Biol Chem; 2004 Feb; 279(9):8497-505. PubMed ID: 14665621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sepsis-induced cardiac mitochondrial dysfunction involves altered mitochondrial-localization of tyrosine kinase Src and tyrosine phosphatase SHP2.
    Zang QS; Martinez B; Yao X; Maass DL; Ma L; Wolf SE; Minei JP
    PLoS One; 2012; 7(8):e43424. PubMed ID: 22952679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rack1 mediates tyrosine phosphorylation of Anxa2 by Src and promotes invasion and metastasis in drug-resistant breast cancer cells.
    Fan Y; Si W; Ji W; Wang Z; Gao Z; Tian R; Song W; Zhang H; Niu R; Zhang F
    Breast Cancer Res; 2019 May; 21(1):66. PubMed ID: 31113450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Src homology phosphotyrosyl phosphatase-2 expression is an independent negative prognostic factor in human breast cancer.
    Muenst S; Obermann EC; Gao F; Oertli D; Viehl CT; Weber WP; Fleming T; Gillanders WE; Soysal SD
    Histopathology; 2013 Jul; 63(1):74-82. PubMed ID: 23672411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A truncated phosphorylated p130Cas substrate domain is sufficient to drive breast cancer growth and metastasis formation in vivo.
    Kumbrink J; de la Cueva A; Soni S; Sailer N; Kirsch KH
    Tumour Biol; 2016 Aug; 37(8):10665-73. PubMed ID: 26867768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SHP2 is up-regulated in breast cancer cells and in infiltrating ductal carcinoma of the breast, implying its involvement in breast oncogenesis.
    Zhou X; Coad J; Ducatman B; Agazie YM
    Histopathology; 2008 Oct; 53(4):389-402. PubMed ID: 18643929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.